8 results
Summary of characteristics of Platelet Aggregation Inhibitors

#AntiPlatelet #Inhibitors #Pharmacology #Table #Overview #Interactions #Pharmacology #Cardiology
Platelet Aggregation Inhibitors ... #AntiPlatelet #Inhibitors ... Table #Overview ... #Interactions #Pharmacology ... #Cardiology
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓)
of cytochrome p450 CYP3A4 and P-glycoprotein.

DOACs are substrates
inducers (↑) and inhibitors ... concentrations, and inhibitors ... by inducers or inhibitors ... Pglycoprotein #inducers #inhibitors ... #Table #Pharmacology
Synercid (Quinupristin/Dalfopristin) (IV) - Antibiotics Class Overview

Mechanism: “Streptogramins”– inhibits sequential steps in ribosomal synthesis
Spectrum: covers MRSA
Antibiotics Class Overview ... Streptogramins”– inhibits ... lots of drug-drug interactions ... (CYP450 inhibitor ... #Pharmacology #Antibiotics
Protease Inhibitors 

Protease Inhibitors are a class of commonly used antiretroviral medications for management of HIV.
Protease Inhibitors ... Protease Inhibitors ... Here's a broad overview ... cobicistat (3A4 INHIBITORS ... #Protease #Inhibitors
Drugs Interacting with Sulfonylureas

Drugs that may reduce the effects of sulfonylureas, leading to loss of glucose
Drugs Interacting ... sulfonylureas, leading ... Monoamine oxidase inhibitors ... #Interactions # ... Pharmacology
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
 • Night-blooming
Cardiovascular Drug-Drug Interactions ... Angiotensin-Converting Enzyme Inhibitors ... Monoamine Oxidase Inhibitors ... supplementals #herbal #pharmacology ... #DDI #table #cardiology
Management of Immune Checkpoint Inhibitor (ICI) Induced Cardiotoxicity
Problem - Immune checkpoint inhibitors (ICIs) are associated with
Immune Checkpoint Inhibitor ... Immune checkpoint inhibitors ... Severity Grading ... #Checkpoint #Inhibitor ... #oncology #management
Management of Anthracyclines and HER2 Antagonist Cardiotoxicity
Anthracyclines cause cardiomyopathy:
 ✖ Reduction in left ventricular ejection fraction
system (RAAS) inhibitor ... prophylactic RAAS inhibitor ... are limited HER2 Inhibitors ... prophylactic RAAS inhibitor ... #oncology #pharmacology